122 related articles for article (PubMed ID: 38253331)
1. Uterine Immunoprivileged Cells Restore Cardiac Function of Male Recipients After Myocardial Infarction.
Peng Z; Ludke A; Wu J; Li S; Alibhai FJ; Zhang Y; Fan Y; Song H; He S; Xie J; Li RK
Stem Cells; 2024 May; 42(5):430-444. PubMed ID: 38253331
[TBL] [Abstract][Full Text] [Related]
2. Uterine-derived progenitor cells are immunoprivileged and effectively improve cardiac regeneration when used for cell therapy.
Ludke A; Wu J; Nazari M; Hatta K; Shao Z; Li SH; Song H; Ni NC; Weisel RD; Li RK
J Mol Cell Cardiol; 2015 Jul; 84():116-28. PubMed ID: 25939780
[TBL] [Abstract][Full Text] [Related]
3. Class II transactivator knockdown limits major histocompatibility complex II expression, diminishes immune rejection, and improves survival of allogeneic bone marrow stem cells in the infarcted heart.
Huang XP; Ludke A; Dhingra S; Guo J; Sun Z; Zhang L; Weisel RD; Li RK
FASEB J; 2016 Sep; 30(9):3069-82. PubMed ID: 27221978
[TBL] [Abstract][Full Text] [Related]
4. Chronic AMD3100 antagonism of SDF-1alpha-CXCR4 exacerbates cardiac dysfunction and remodeling after myocardial infarction.
Dai S; Yuan F; Mu J; Li C; Chen N; Guo S; Kingery J; Prabhu SD; Bolli R; Rokosh G
J Mol Cell Cardiol; 2010 Oct; 49(4):587-97. PubMed ID: 20655922
[TBL] [Abstract][Full Text] [Related]
5. Soluble donor-like MHC class I proteins induce CD4(+)CD25(+)CD8(-)FoxP3(+) cells with potential to ameliorate graft chronic injury.
Andakyan A; Burruss S; Hong LS; Shen XD; Romanov S; Gao F; Feldman DM; Fishbein MC; Semiletova NV
Transpl Immunol; 2011 May; 24(4):203-9. PubMed ID: 21251981
[TBL] [Abstract][Full Text] [Related]
6. Induced pluripotent stem cell (iPSC)-derived Flk-1 progenitor cells engraft, differentiate, and improve heart function in a mouse model of acute myocardial infarction.
Mauritz C; Martens A; Rojas SV; Schnick T; Rathert C; Schecker N; Menke S; Glage S; Zweigerdt R; Haverich A; Martin U; Kutschka I
Eur Heart J; 2011 Nov; 32(21):2634-41. PubMed ID: 21596799
[TBL] [Abstract][Full Text] [Related]
7. Tissue factor cytoplasmic domain exacerbates post-infarct left ventricular remodeling via orchestrating cardiac inflammation and angiogenesis.
Chong SY; Zharkova O; Yatim SMJM; Wang X; Lim XC; Huang C; Tan CY; Jiang J; Ye L; Tan MS; Angeli V; Versteeg HH; Dewerchin M; Carmeliet P; Lam CSP; Chan MY; de Kleijn DPV; Wang JW
Theranostics; 2021; 11(19):9243-9261. PubMed ID: 34646369
[TBL] [Abstract][Full Text] [Related]
8. Kinetics of transplant arteriosclerosis in MHC-Class I mismatched and fully allogeneic mouse aortic allografts.
Ensminger SM; Spriewald BM; Witzke O; Morrison K; Pajaro OE; Morris PJ; Rose ML; Wood KJ
Transplantation; 2002 Apr; 73(7):1068-74. PubMed ID: 11965033
[TBL] [Abstract][Full Text] [Related]
9. Modulation of Alloimmune Responses by Interleukin-10 Prevents Rejection of Implanted Allogeneic Smooth Muscle Cells and Restores Postinfarction Ventricular Function.
Dhingra S; Wu J; Li SH; Guo J; Huang XP; Mihic A; Hu J; Weisel RD; Li RK
Cell Transplant; 2015; 24(6):1013-29. PubMed ID: 24784322
[TBL] [Abstract][Full Text] [Related]
10. Conferring indirect allospecificity on CD4+CD25+ Tregs by TCR gene transfer favors transplantation tolerance in mice.
Tsang JY; Tanriver Y; Jiang S; Xue SA; Ratnasothy K; Chen D; Stauss HJ; Bucy RP; Lombardi G; Lechler R
J Clin Invest; 2008 Nov; 118(11):3619-28. PubMed ID: 18846251
[TBL] [Abstract][Full Text] [Related]
11. Safety and efficacy of allogeneic cell therapy in infarcted rats transplanted with mismatched cardiosphere-derived cells.
Malliaras K; Li TS; Luthringer D; Terrovitis J; Cheng K; Chakravarty T; Galang G; Zhang Y; Schoenhoff F; Van Eyk J; Marbán L; Marbán E
Circulation; 2012 Jan; 125(1):100-12. PubMed ID: 22086878
[TBL] [Abstract][Full Text] [Related]
12. CD8+ lymphocytes augment chronic rejection in a MHC class II mismatched model.
Fischbein MP; Yun J; Laks H; Irie Y; Fishbein MC; Espejo M; Bonavida B; Ardehali A
Transplantation; 2001 Apr; 71(8):1146-53. PubMed ID: 11374417
[TBL] [Abstract][Full Text] [Related]
13. Tumour-specific CTL response requiring interactions of four different cell types and recognition of MHC class I and class II restricted tumour antigens.
Schirrmacher V; Schild HJ; Gückel B; von Hoegen P
Immunol Cell Biol; 1993 Aug; 71 ( Pt 4)():311-26. PubMed ID: 7901150
[TBL] [Abstract][Full Text] [Related]
14. The influence of MHC and non-MHC genes on the nature of murine cardiac allograft rejection. I. Kinetic analysis of mononuclear cell infiltrate and MHC-class I/class II expression in donor tissue.
Wang YC; Mayne A; Sell KW; Ahmed-Ansari A
Transplantation; 1990 Aug; 50(2):313-24. PubMed ID: 2200176
[TBL] [Abstract][Full Text] [Related]
15. MHC class II-mediated antigen presentation by alloreactive rat CD4+ T cells does not induce regulatory properties.
Otto C; Heeg A; Kottenmeier S; Tiurbe GC; Thiede A; Ulrichs K
Transplant Proc; 2006 Apr; 38(3):755-6. PubMed ID: 16647463
[TBL] [Abstract][Full Text] [Related]
16. Transplantation of CREG modified embryonic stem cells improves cardiac function after myocardial infarction in mice.
Zhang J; Tian X; Peng C; Yan C; Li Y; Sun M; Kang J; Gao E; Han Y
Biochem Biophys Res Commun; 2018 Sep; 503(2):482-489. PubMed ID: 29684345
[TBL] [Abstract][Full Text] [Related]
17. In vivo treatment with interferon-gamma during early pregnancy in mice induces strong expression of major histocompatibility complex class I and II molecules in uterus and decidua but not in extra-embryonic tissues.
Mattsson R; Mattsson A; Holmdahl R; Scheynius A; Van der Meide PH
Biol Reprod; 1992 Jun; 46(6):1176-86. PubMed ID: 1391316
[TBL] [Abstract][Full Text] [Related]
18. Prevention and restoration of second-set liver allograft rejection in presensitized mice: the role of "passenger" leukocytes, donor major histocompatibility complex antigens, and host cytotoxic effector mechanisms.
Fu F; Li W; Lu L; Thomson AW; Fung JJ; Qian S
Transplantation; 1999 Feb; 67(3):444-50. PubMed ID: 10030293
[TBL] [Abstract][Full Text] [Related]
19. Syngeneic bone marrow expressing a single donor class I MHC molecule permits acceptance of a fully allogeneic cardiac allograft.
Wong W; Morris PJ; Wood KJ
Transplantation; 1996 Nov; 62(10):1462-8. PubMed ID: 8958273
[TBL] [Abstract][Full Text] [Related]
20. Expansion of CD10
Fraccarollo D; Neuser J; Möller J; Riehle C; Galuppo P; Bauersachs J
Elife; 2021 Jul; 10():. PubMed ID: 34289931
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
